YDES
YD Bio Limited Ordinary Shares
通常取引データ（自動更新なし）RVOL 0.1xDV $405,81720日平均DV $5M?
52W high -66.3%52W low +336.5%Market cap $526MAvg volume 695K
Company Overview
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2025 Q2 | -0.65 | $0 | -$298,190 |
| 2025 Q1 | -0.98 | $0 | -$490,410 |
| 2024 Q4 | 0.10 | $0 | -$365,650 |
| 2024 Q3 | 0.54 | $0 | -$21,570 |
| 2024 Q2 | 4.05 | $0 | -$592,520 |
| 2024 Q1 | -5.12 | $0 | -$629,740 |
|
